Login Open account
Australia
Are European equities worth pursuing? Are European equities worth pursuing? Are European equities worth pursuing?

Are European equities worth pursuing?

Equities 7 minutes to read
PG
Peter Garnry

Head of Equity Strategy

Summary:  Equity markets have diverged since the financial crisis with US markets outperforming their European counterparts by a wide margin. The question is, is this set to continue?

In our Q2 Quarterly Outlook published today, we argue that equity markets have diverged since the financial crisis in 2008. US equity markets have outperformed their European counterpartss by a large margin and profit growth has also been much stronger among US companies. The three main drivers of this divergence are higher US fiscal impulse, earlier QE in the US restoring balance sheets among US banks and lastly the US technology sector dominating monetisation in the Internet age.

US equities consequently trade at a large valuation premium of around 40% to European equities. The bigger question is whether this will continue into the future?

Strong trends in favour of the US

Long-term US earnings growth will likely be larger than Europe’s due to the three factors mentioned above. The US is likely to have higher fiscal deficits going forward as there is little will in Europe to increase government spending due to the euro area crisis in 2010-2012. As long as Europe does not do deeper fiscal and monetary integration, fiscal policies will likely be constrained compared to the US.

From a sectoral balance perspective, the larger US deficit will underpin profits in the private sector and serve as an engine for further gains in the US equity market. The monopolistic nature of many industries is most striking in the technology sector, where a few US companies completely dominate their niche segments, extracting excess profits.

While the EU has done some initial groundwork to weaken US technology companies. their power will only diminish very slowly, at best... think Microsoft.
Cumulative growth
In addition, US banks are healthy and thus credit enablers to a larger degree than their European counterparts. This stimulates profit growth for US banks which are still the second-largest segment of the US equity market. For long-term investors, US equities should most likely be overweighted against European equities. 

Opportunities in European equities

Long-term dynamics is one game, short-term . In our equity outlook we expressed a negative view on European equities short-term based on Europe’s leading indicators being below trend and still falling as of January 2019. This environment (first column in table below) is typically negative on average for global equities, but in particular for European shares. In our outlook, we offer hope by highlighting that leading indicators for South Korea have already turned higher and evidence shows that South Korea has led global growth since 2008.

Yesterday’s March PMI figures on China and South Korea also confirmed that Chinese stimulus is beginning to work. We have increased the probability that OECD’s leading indicator published on April 8 will likely show that Asia has already turned and that sentiment will improve in Europe within three months.
Equities
When the cycle shifts to the next phase, below trend but expanding, investors should increase their exposure to Asia Pacific and North America. Europe has historically been weak in the recovery phase. Only very cyclical countries such as the Netherlands, Norway, Sweden and United Kingdom have shown attractive dynamics in this part of the economic cycle.

From a broader perspective, Europe does not deliver high returns until late into the short-term economic cycle. The big unknown against historical returns in the various economic cycles is Europe’s low valuation with German equities valued at a 35% discount to global equities. This could be so attractive that European equities might surprise to the upside when the economic cycle turns.

So our view on equities is still cautious/defensive with an overweight/positive view on early cyclical countries such as Australia, Hong Kong, South Korea and India.

Quarterly Outlook 2024 Q2

2024: The wasted year

01 / 05

Macro: It’s all about elections and keeping status quo

Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.

Read article

FX: The rate cut race shifts into high gear

As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.

Read article

Equities: The AI and obesity rally is defying gravity

Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.

Read article

Fixed income: Keep calm, seize the moment

With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.

Read article

Commodities: Is the correction over?

Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.

Read article

  • Macro: It’s all about elections and keeping status quo

    Markets are driven by election optimism, overshadowing growing debt and liquidity concerns. The 2024 elections loom large, but economic fundamentals and debt issues warrant cautious investment.

    Read article

  • FX: The rate cut race shifts into high gear

    As US economic slowdown hints at a shift away from exceptionalism, USD faces downside with looming Fed cuts. AUD and NZD set to outperform as their rate cuts lag. JPY gains on carry unwind bets and BOJ pivot.

    Read article

  • Equities: The AI and obesity rally is defying gravity

    Amid AI and obesity drug excitement, equities see varied prospects: neutral on overvalued US stocks, negative on Japan due to JPY risks, positive on Europe. European defence stocks gain appeal.

    Read article

  • Fixed income: Keep calm, seize the moment

    With the economic slowdown, quality assets will gain favour, especially sovereign bonds up to 5 years. Central banks' potential rate cuts in Q2 suggest extending duration, despite policy and inflation concerns.

    Read article

  • Commodities: Is the correction over?

    Commodities poised for rebound. The "Year of the Metal" boosts gold and silver, copper awaits rate cuts. Grains may recover, natural gas stabilises. Gold targets $2,300-$2,500/oz, copper's breakout could signal growth.

    Read article
Disclaimer

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at https://www.home.saxo/en-au/legal/.

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (https://www.home.saxo/en-au/legal/disclaimer/saxo-disclaimer)
- Analysis Disclaimer (https://www.home.saxo/en-au/legal/analysis-disclaimer/saxo-analysis-disclaimer)
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000
Australia

Contact Saxo

Select region

Australia
Australia
Products & pricing
Asset Management
Platforms
Accounts & service
General
Other
Legal

Trading can result in losses. Please ensure you understand the risks.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-au/about-us/awards

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.